Sign up
Quantellect · Congress · Politician Profile
Q Score Rank#58 of 77

Cliff Bentz Stock Trades

U.S. Representative · Republican-OR
UnknownConsumer DefensiveHealthcare

Congressional Stock Trades & Disclosures

Cliff Bentz is a U.S. Representative, a Republican representing OR. As of May 2026, Quantellect has tracked 6 disclosed stock trades across 5 companies, representing $415.00K in disclosed transaction value, each filed publicly under the STOCK Act.

About Cliff Bentz's congressional trading

Cliff Bentz Trading Profile | Quantellect Cliff Bentz Trading Profile

Cliff Bentz has disclosed six transactions between November 21, 2022 and April 9, 2026, and three of the four most recent transaction rows are attributed to his spouse rather than to him. The pattern is low-frequency: one or two disclosed transactions in each year represented, split among individual equities, Treasury notes and a bond ETF. The record does not show a concentrated equity-sector theme, with the three equity transactions spread across health care, consumer staples and information technology.

The Oregon Republican, who represents the state's 2nd District and began his current House term on January 3, 2025, carries a Quantellect Score of 25, placing him 59th of 77 scored members. His score is assigned to the "mixed" tier, while the supplied coverage state is labeled "thin."

A pattern of infrequent trades

Bentz's earliest disclosed transaction on record is a sale dated November 21, 2022, and the most recent is a sale dated April 9, 2026, giving a disclosed trading history spanning that period. Across those six transactions, three were purchases and three were sales, with no transactions falling outside those two categories. Attribution matters here: three of the six transactions are marked "Self," meaning Bentz is the attributed owner, while the other three carry the "Spouse" attribution code and should not be presented as his personal trading decisions.

Every transaction attributed to Bentz's spouse falls in the more recent window. The two purchases have a transaction date of June 6, 2025 and a disclosure date of July 9, 2025, while the sale has a transaction date of April 9, 2026 and a disclosure date of May 9, 2026. The three "Self" transactions are the older ones, dated between November 2022 and January 2024. That marks a shift in the disclosed attribution during the more recent part of the record: recent activity is spouse-attributed, not Bentz's own disclosed trading.

By year, the disclosed record shows one transaction in 2022 (a sale), one in 2023 (a purchase), one in 2024 (a sale), two in 2025 (both purchases), and one in the supplied 2026 record (a sale). There is no year with more than two disclosed transactions, underscoring how sparse this trading record is.

What was bought and sold

The two 2025 transactions, both dated June 6 and attributed to Bentz's spouse, were purchases in Amgen Inc (AMGN) and Procter & Gamble Company (PG), each in the $1,001 to $15,000 range. Amgen is a biotechnology company whose products include Enbrel, Otezla, Prolia, Repatha and other therapeutics sold to healthcare providers and hospitals worldwide, and it is classified in the packet's data as Health Care, specifically Biotechnology. Procter & Gamble is a branded consumer packaged goods company spanning beauty, grooming, health care, fabric and home care, and baby and family care, with well-known brand lines including Tide, Pampers, Gillette and Crest, and it falls under Consumer Staples, specifically Household Products.

The most recent disclosed transaction, dated April 9, 2026 and also attributed to the spouse, was a sale of Intel Corporation (INTC) common stock in the $1,001 to $15,000 range. Intel designs and manufactures computing and semiconductor products through its CCG, DCAI and Intel Foundry segments, serving original equipment manufacturers and cloud service providers, and is classified under Information Technology, specifically Semiconductors & Semiconductor Equipment.

The largest transaction on record by disclosed dollar range is the November 2022 sale, attributed to Bentz himself, of the iShares Core US Aggregate Bond ETF (AGG), in the $250,001 to $500,000 range. Every other transaction in the supplied record falls in the $1,001 to $15,000 range. The two remaining "Self" transactions involved US Treasury notes: a purchase in April 2023 of a Treasury note due January 2024, and a sale in January 2024 of a Treasury note due that month. Both were disclosed in the $1,001 to $15,000 range. Together, these earlier transactions show fixed-income activity under the "Self" attribution, distinct from the equity purchases and sale that later appeared under the spouse attribution.

Sector activity and what it does not show

Of the six disclosed transactions, three fall under a sector marked "Unknown" in the record, reflecting the Treasury-note transactions and the AGG bond ETF sale, which are not assigned an equity-sector classification. The remaining three transactions are split one apiece across Consumer Staples, Health Care and Information Technology, meaning no single equity sector accounts for more than one disclosed trade. That distribution is too sparse to establish a sector preference or investment theme; it reads instead as a small handful of individual-company transactions alongside earlier fixed-income activity.

Disclosure and sourcing notes

This profile reflects only the transactions disclosed in Cliff Bentz's filings under the Stop Trading on Congressional Knowledge Act of 2012, as filed with the House Clerk's office and governed by the House Committee on Ethics financial disclosure instruction guide. Dollar amounts reflect disclosed ranges, not exact values. Transactions marked with a spousal attribution are attributed to a spouse and should not be treated as decisions made personally by the member. Underlying filings are available via the House Clerk's disclosure system, including the 2022 filing, 2023 filing, 2024 filing, 2025 filing and 2026 filing.

Trading activity

Trades
6
Companies
5
Disclosed Vol
$415.00K
Buys
3
50%
Sells
3
50%
Buy / Sell
1.00
ratio

Estimated trading profits

Estimated unrealized profit+$3K
Estimated excess vs S&P 500-$1K (-7.3%)
Win rate50% (1 of 2 buys up)
Average return+20.5%

Based on 2 of 2 disclosed buys with pricing coverage.

Aug 26, 2025 to Aug 25, 2026

Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.

Where the Money Sits

share of disclosed trades · top sectors

Periodic Transaction Report filings

CompanyTypeSizeTradedEst. priceChange
INTCIntel Corporation
Sell$1,001 - $15,00009 APR 2026$61.72+41.74%
PGProcter & Gamble Company
Buy$1,001 - $15,00006 JUN 2025$159.43-8.80%
AMGNAmgen Inc
Buy$1,001 - $15,00006 JUN 2025$281.86+56.90%
US Treasury Note 1.25% - Jan 15, 2024
Sell$1,001 - $15,00016 JAN 2024
US Treasury NT .0125% Note Due 1/15/24
Buy$1,001 - $15,00003 APR 2023
AGGEvolve Canadian Aggregate Bond Enhanced Yield Fund ETF
Sell$250,001 - $500,00021 NOV 2022$85.19+15.05%
Prev1Next
Go to

Congressional trading news

The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.

Cliff Bentz congressional trading FAQ

Can Cliff Bentz legally trade stocks?

Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Cliff Bentz's disclosures so the public can review them.

Where does Quantellect get Cliff Bentz's trading data?

Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.

How can I track Cliff Bentz's stock trades?

Quantellect tracks every stock trade Cliff Bentz discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.

How many stock trades has Cliff Bentz disclosed?

Quantellect has tracked 6 disclosed trades by Cliff Bentz across 5 companies.

Which stocks does Cliff Bentz trade most?

Cliff Bentz's most frequently disclosed positions are AGG (1 disclosed trade), AMGN (1 disclosed trade), INTC (1 disclosed trade), and PG (1 disclosed trade). The full list of companies and individual filings is shown on this page.

What was Cliff Bentz's most recent stock trade?

Cliff Bentz most recently sold Intel Corporation (INTC) in April 2026, according to public STOCK Act filings tracked by Quantellect.

What is Cliff Bentz's Quantellect Score?

Cliff Bentz has a Quantellect Score of 26 out of 100 (Mixed). The score ranks members by the estimated unrealized results of their disclosed buys over the last 24 months, weighting estimated total profit, profit versus the S&P 500, and win rate. It is a descriptive research signal, not investment advice or an allegation of unlawful trading.

How much has Cliff Bentz made trading stocks?

Quantellect estimates Cliff Bentz's disclosed buys show an estimated unrealized profit of $3,278 over the trailing 12 months, based on priced disclosed buy transactions through August 25, 2026. This is an estimate and does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. It is descriptive research, not investment advice or an allegation of wrongdoing.

Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.